About Contact Us Careers
Sign In

Ibuprofen API Market - Top Companies and Manufacturers

  • Report ID: 5471
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Companies Dominating the Ibuprofen API Market

    • Azelis
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Lonza
    • BIOCAUSE Inc.
    • IOL Chemicals and Pharmaceuticals Limited
    • Granules India Limited
    • SALVAVIDAS PHARMACEUTICAL PVT. LTD.
    • Sri Krishna Pharmaceuticals Ltd.
    • Taj Pharmaceuticals Limited
    • Anantco Enterprises Pvt. Ltd.
    • Wellona Pharma
Browse Key Market Insights with Data Illustration:

In the News

  • September 19, 2022: Azelis, a prominent worldwide innovation service provider in the food additives and specialty chemicals sector, is pleased to announce that it has entered into a new distribution deal with the esteemed specialty chemical manufacturer Clariant. Customers of Azelis in Austria, Germany, and Switzerland now have instant access to the whole line of active pharmaceutical ingredients (API) and excipients from Clariant.
  • March 8, 2022: At its active pharmaceutical ingredients (API) manufacturing facility in Nansha, China, Lonza, a global manufacturing partner to the biotech, nutrition, and pharmaceutical industries, today announced the completion of a laboratory expansion. With regard to the clinical supply of highly-potent APIs (HPAPI), the expansion primarily aimed to increase the capabilities and capacity of development laboratories and kilogram-scale cGMP manufacturing laboratories.

Author Credits:  Radhika Pawar


  • Report ID: 5471
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of ibuprofen API is estimated at USD 727.09 million.

The ibuprofen API market size was over USD 715.08 million in 2024 and is expected to cross USD 936.89 million by the end of 2037, growing at more than 2.1% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by growth in number of women menstruating, rise in need for growth in drug development, and surge in prevalence of musculoskeletal disorders in pediatrics.

Asia Pacific industry is set to account for largest revenue share 35% by 2037, owing to low manufacturing cost of manufacturing medicines in the region.

The major players in the market are Azelis, Lonza, BIOCAUSE Inc., IOL Chemicals and Pharmaceuticals Limited and others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample